Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 non-treatment cardiovascular follow-up after smoking cessation treatments
2011-005513-37Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of varenicline, bupropion and nicotine in nicotine dependence (4 arms), sponsored by Pfizer. Primary endpoint: Time to major adverse cardiovascular event during treatment phase. Started Jan 2012; status: completed.
02
Drugs
vareniclinebupropionnicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2011-005513-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005513-37.